Zurich Cantonal Bank’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $192K | Buy |
20,541
+7,281
| +55% | +$68.2K | ﹤0.01% | 2156 |
|
2025
Q1 | $163K | Sell |
13,260
-4,731
| -26% | -$58.1K | ﹤0.01% | 2197 |
|
2024
Q4 | $238K | Buy |
17,991
+5,771
| +47% | +$76.3K | ﹤0.01% | 2071 |
|
2024
Q3 | $235K | Sell |
12,220
-15
| -0.1% | -$289 | ﹤0.01% | 2024 |
|
2024
Q2 | $251K | Sell |
12,235
-6,057
| -33% | -$124K | ﹤0.01% | 1925 |
|
2024
Q1 | $435K | Buy |
18,292
+4,166
| +29% | +$99.2K | ﹤0.01% | 1560 |
|
2023
Q4 | $305K | Buy |
14,126
+1,162
| +9% | +$25.1K | ﹤0.01% | 1830 |
|
2023
Q3 | $188K | Sell |
12,964
-108
| -0.8% | -$1.57K | ﹤0.01% | 2005 |
|
2023
Q2 | $274K | Buy |
13,072
+3,439
| +36% | +$72K | ﹤0.01% | 1720 |
|
2023
Q1 | $203K | Sell |
9,633
-99
| -1% | -$2.09K | ﹤0.01% | 1851 |
|
2022
Q4 | $248K | Buy |
9,732
+1,272
| +15% | +$32.4K | ﹤0.01% | 1699 |
|
2022
Q3 | $203K | Hold |
8,460
| – | – | ﹤0.01% | 1747 |
|
2022
Q2 | $163K | Buy |
8,460
+3,187
| +60% | +$61.4K | ﹤0.01% | 1920 |
|
2022
Q1 | $92K | Sell |
5,273
-1,033
| -16% | -$18K | ﹤0.01% | 2322 |
|
2021
Q4 | $138K | Sell |
6,306
-176
| -3% | -$3.85K | ﹤0.01% | 2328 |
|
2021
Q3 | $124K | Buy |
6,482
+9
| +0.1% | +$172 | ﹤0.01% | 2209 |
|
2021
Q2 | $111K | Buy |
6,473
+1,729
| +36% | +$29.6K | ﹤0.01% | 2168 |
|
2021
Q1 | $106K | Buy |
+4,744
| New | +$106K | ﹤0.01% | 2131 |
|